Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04497584
Title Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center

lung squamous cell carcinoma


Afatinib + Prednisone

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.